The impact of prior therapy with ketoconazole (keto) on clinical outcomes after subsequent docetaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) patients: Results from a randomized phase III trial (CALGB 90401).
- Citation:
- J Clin Oncol vol 30 (15 suppl) abstr 4667
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2004
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. J. Small S. Halabi M. A. Carducci C. J. Ryan D. J. George J. F. Mahoney W. M. Stadler M. J. Morris P. Kantoff J. P. Monk W. K. Kelly
- Networks:
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: